Hrkach and Langer et al. developed ACUPA (PSMA ligand) conjugated DTX NPs composed of PEG-b-PLGA or PEG-b-PLA using a nano-emulsification method to target PSMA and evaluated the anti-tumor efficacy of the NPs in vitro and in vivo[18]. This evidence concerns the gene FOLH1 and neoplasm.